Zoom Logo

FDA-OCE Conversations on Cancer: National Black Family Cancer Awareness Week - Shared screen with speaker view
Amy Kleger
02:52:04
yes! through Penn Medicine in Philadelphia
FDA OCE (Tony Cossentino)
02:52:35
Question from Attendee, Natalee: Where can I find the stats on Cancer killers for men & women that was just mentioned?
Cassandra Harris
02:53:49
involving community in research development via community scientists programs, community studios may also impact beliefs about clinical trial participation and research in general
John Carpten
02:55:03
American Cancer Society website is a great resource for statistics.
Otis Brawley
02:55:09
The easiest to get to source of cancer data is The American Cancer Society "Cancer Facts and Figures" It is published every January and is free on the web as a PDF. Google it or https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2021.html
Jeanne Regnante
02:55:33
https://www.cancer.org/latest-news/facts-and-figures-2021.html#:~:text=Facts%20%26%20Figures%202021%20Reports%20Another%20Record-Breaking%201-Year,half%20of%20them%20in%20their%2050s%20and%20younger.
John Carpten
02:57:29
ACS also puts out statistics for African Americans and Hispanic/Latinos as well, and compare rates across populations.
Otis Brawley
02:58:23
www.seer.cance.gov is a great source for incidence and death rates. It does not give absolute numbers bur rates per 100,000. Lay people have to be careful in the interpretation. This is how epidemiologists look at population statistics.
Otis Brawley
02:58:36
www.seer.cacner.gov is the website
Debbie L. Cadet
02:58:59
https://www.cancer.org/latest-news/facts-and-figures-2021.html
Otis Brawley
02:59:35
www.seer.cancer.gov I will get it right eventually
Claudia Barajas - Vanderbilt-Ingram Cancer Center
03:01:08
Increase Clinical trials participation by engaging with people in their own communities, speak their language, listening to their concerns and providing education and information about new clinical trials
Rochelle Williams-Belizaire
03:06:54
https://pubmed.ncbi.nlm.nih.gov/33022716/ When Offered to Participate": A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials
Eunice Artis (She/Her)
03:09:17
Dr. Pazdur's point about POC participating in early phase clinical trials is critical!
Rolondo Enoch
03:11:00
I agree Eunice and is why I am here on this call to learn of different efforts to get underrepresented minorities (i.e. Black, LatinX and Native Americans) participation/enrollment in clinical trials.
Jeanne Regnante
03:11:01
can the experts comment about JAMA recommending that all human trials including OMB-HSS demographics as part of baseline characteristcs- and do you advocate for all journal editors to do the same ?
Michelle M
03:11:05
What is the Black/AA enrollment in prevention & screening CTs- those for people without cancer, but at risk? Is the participation rate higher for these or about the same?
Voncile Brown-Miller
03:11:41
Phase 1 trails are not attractive because they are phase 1 people want to benefit from being on a clinical trail. They want benefit.
Claudia Barajas - Vanderbilt-Ingram Cancer Center
03:14:09
expand inclusion criteria to participants that speak other language that English like Spanish, Arabic and others
Jeanne Regnante
03:14:34
Amen,, other subspecialists, PCP need to be trained-- PCPs think of cancer clinical trials as last resort.. a good effort to take up with the professional societies
Rochelle Williams-Belizaire
03:14:48
There is a trend in industry and academic for patient advocacy programs but the conversations tend to not be bidirectional
Kristin Miller
03:14:51
YES!
Julia Forth, CSCLA
03:15:33
Absolutely! Community connectedness is key!
Anthony Clark
03:16:39
Social economical status often hampers AA patients from participating. Transportation, taking off of work. Does the academic centers offer support in these areas to support or recruit patients into clinical trials.
Kearston Ingraham, MPH (She/Her)
03:17:14
Thank you for having this event- I am learning so much about the FDA process in diversifying clinical trial participants. If an investigator receives FDA funding for their research, is there a required line item in their budget to address training/outreach efforts for the research team as a means for them to meaningfully engage traditionally medically underserved communities in their FDA-funded research?
Rochelle Williams-Belizaire
03:17:17
Agreed, there is a massive intersection between public health and clinical research - particularly when we think about the immune-oncology landscape. Why are we not taking advantage of community health needs assessments when we design clinical trials. The community is always considered last - coming from someone that sits and designs clinical trials in the academic space
Voncile Brown-Miller
03:17:38
We need to speak our younger community to build an understanding of the science of it all. We wait until people
Voncile Brown-Miller
03:18:03
are in need to introduce clinical trail that is too late.
D Gathers
03:18:27
@anthony clark this is an interesting question - as a trainee, I rarely see opportunities for financial support in those specific areas to facilitate increased participation in clinical trials. I wonder also if there would be any conflict of interest issue in doing that..
Janet Fernandez
03:18:34
How is the impact of the disparity in clinical trial participation by minority patients in the current era of cancer immunotherapy being addressed?
D Gathers
03:20:13
very true, academic centers in communities are often perceived as "ivory towers" as opposed to rooted and connected
D Gathers
03:22:47
so true, dr. winn
Jeanne Regnante
03:23:36
must include community leaders in all grants as partners for inclusive research. Period ( in the meantime)
Claudia Hardy (she/her)
03:23:37
(Dr.) Robert Winn is ON POINT! We have to be truly engaged and immersed in our communities whether we have funding or not!
Claudia Barajas - Vanderbilt-Ingram Cancer Center
03:24:30
Agree with Dr Winn and Claudia Hardy's comment!
Rochelle Williams-Belizaire
03:24:32
Awarenesses is great but what are the resources that are available when someone takes a screening test and is diagnosed? That has to be planned effectively.
Cassandra Harris
03:25:59
I agree with Claudia. Researchers should work in collaboration with public health and community health educators to impact change in our current system. Cancer Center researchers and Community Outreach and Engagement Teams are beginning to work together.
Claudia Hardy (she/her)
03:26:36
It has taken NCI nearly 45 -50 years to ensure that
Claudia Hardy (she/her)
03:26:53
COE is fully integrated in the NCI designated cancer centers
Rolondo Enoch
03:32:39
and let the church say, "Amen"
Heather Badt
03:32:51
Way to go!
Ivory Allison
03:33:05
that's awesome, Brian!
Claudia Hardy (she/her)
03:33:16
Go Brian!
Michelle M
03:33:16
Wonderful testimony!
Cassandra Harris
03:33:21
Awesome Dr. Rivers
Ivory Allison
03:35:07
Liver Cancer is on the rise in African American men and Native Americans, but it isn't talked about much, even among professionals. Why do you think that is?
D Gathers, UNM PGY4
03:38:57
that's amazing
Karen Ambrogi
03:48:48
My foundation (Lazarex Cancer Foundation) is pursuing a mutli (cancer industry) stakeholder effort to understand the state of cancer in vulnerable communities - through a place based, community-led model of engagement, developing an approach and team of community advocates. In this case the pilot program is at the Drexel Center for Neighborhood Partnerships in West Philadelphia, and the goal is to extend this model out to other neighborhoods, medical, and academic centers in Philadelphia through peer-to-peer community leadership and direction. Here is the state of cancer in Philadelphia report: https://drexel.edu/uhc/research/projects/community-impact-reducing-cancer/Basic%20Page/ and the Community IMPACT program: https://drexel.edu/uhc/research/projects/community-impact-reducing-cancer/. To Dr. Winn's point - these are grants and so we work really hard to secure funding to continue to keep these programs going. We do have Pharma funding for these programs FYI.
Marc Johnson, AACR
03:49:23
https://cancerprogressreport.aacr.org/disparities/
Valerie Vinson
03:50:17
excellent conversation thank you!
Heather Badt
03:51:17
thank you!
Debbie L. Cadet
03:51:32
This was an outstanding conversation, one of many more to come! Please get involved with building the science pipeline http://gmapr1.com/aboutgmap/
Cassandra Harris
03:52:22
thanks Debbie
Ivory Allison
03:53:00
Great conversation
Julia Forth, CSCLA
03:53:01
Excellent talk! Thank you!
Janet Fernandez
03:53:04
This has been an incredible webinar. Thank you!
Alesha Arnold
03:53:18
Excellent conversation. Thank you
Tina Werblin
03:53:29
Excellent presentation!
Dawn Patillo Exum
03:53:45
EXCELLENT webinar!!!!
Angela Williams
03:53:53
Excellent. Thank you so much!!
Karen Ambrogi
03:53:55
Thank you for this discussion!!